該雜志國(guó)際簡(jiǎn)稱:CROHNS COLITIS 360,是由出版商Oxford University Press出版的一本致力于發(fā)布--研究新成果的的專業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。
Crohns&Colitis 360 is a peer-reviewed medical journal dedicated to the field of inflammatory bowel disease (IBD). This journal covers basic and clinical research on diseases such as Crohn's disease and ulcerative colitis. The content of the journal aims to promote understanding of these complex diseases, improve patient care, and explore new treatment methods. Crohns&Colitis 360 provides a platform for researchers, doctors, and other healthcare professionals to share their research findings and clinical experiences.
This journal has made significant contributions to the study of inflammatory bowel disease by publishing original research papers, review articles, case reports, and thematic discussions. Its target readership includes gastroenterologists, immunologists, pathologists, surgeons, and other medical professionals engaged in IBD research and treatment. Through these studies, it has helped drive scientific progress and improve clinical practice in this field.